Article
Impact of clinical factors on outcome of leukemia patients with TLS-ERG fusion gene.
Leukemia & lymphoma - 1 Jul 2017
Pan Jing, Zhang Yang, Zhao Yan-Li, Yang Jun-Fang, Zhang Jian-Ping, Liu Hong-Xing, Wu Tong, Tong Chun-Rong
Abstract excerpt
We report the clinical features and outcome of 22 TLS-ERG+leukemia patients (20 AML and 2 B-ALL). TLS-ERG was tightly associated with extramedullary disease (EMD), complex chromosome abnormalities, and high risk gene mutations including IKZF1, WT1, TET2, NOTCH2, and PHF6. The 6-month leukemia free survival (LFS) with and without EMD was 75% and 83.3% (p = .017). 11/20 AML patients received allogeneic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
